Bladder cancer patients monitored years after experimental treatment
NCT ID NCT05981131
First seen May 05, 2026 · Last updated May 05, 2026
Summary
This study checks on patients who previously received an experimental treatment (N-803 plus BCG) for non-muscle invasive bladder cancer. Researchers want to see how they are doing years later, including cancer status, survival, and any further treatments. Only 6 patients who were in the earlier phase 1b trial are included.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NON-MUSCLE INVASIVE BLADDER CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Island Urology
Honolulu, Hawaii, 96813, United States
Conditions
Explore the condition pages connected to this study.